Prof. Maria Rosa Gigliobianco | Nanotechnology and cosmetics research | Best Researcher Award
Reseacher at University G. D’Annunzio of Chieti and Pescara | Italy
Dr.Maria Rosa Gigliobianco is a pharmaceutical scientist and researcher specializing in nanomedicine and drug delivery systems. Currently serving as a researcher (RTD-A) at the University of G. d’Annunzio, she is the Principal Investigator of a government-funded project on nanonetwork strategies for cancer treatment. Her work bridges pharmaceutical chemistry and biomedical innovation, focusing on novel biomaterials, hydrogels, and nanoparticle-based systems. With experience across European institutions and participation in prestigious fellowships like the Marie Skłodowska-Curie, Dr. Gigliobianco has become a recognized expert in drug delivery and formulation. Her dynamic career has impacted biomedical research and the development of targeted therapeutic systems.
Profile:
Orcid | Google Scholar
Education:
Dr.Maria Rosa Gigliobianco earned dual Master’s degrees in Pharmacy and Pharmaceutical Chemistry and Technology from the University of Camerino, where she also completed a Ph.D. in Chemical and Pharmaceutical Sciences and Biotechnologies. Her doctoral research involved synthesizing and characterizing targeted polymeric nanoparticles for biomedical applications, integrating techniques such as DLS, NMR, HPLC, FTIR, SEM, and in vitro studies. She holds a pharmacist license and has built a solid foundation in formulation science and nanoparticle engineering. Her academic training has provided her with a multidisciplinary edge that complements her postdoctoral research in cosmetic, pharmaceutical, and biomaterial-based drug delivery innovations.
Professional Experience:
Dr.Maria Rosa Gigliobianco’s professional journey spans academia and international research centers. She has held multiple postdoctoral positions at the University of Camerino and served as a senior scientist at Percuros BV in the Netherlands under the MSCA Individual Fellowship. Her career includes significant contributions to cancer nanotherapy, nose-to-brain delivery systems, and the formulation of natural biomaterials. Currently, she leads a nanonetwork cancer therapy project as PI. Dr. Gigliobianco has also been a visiting researcher at LUMC in Leiden and lectures as a subject expert in pharmaceutical technology. Her mentorship of over 30 master’s students and 10 Ph.D. researchers demonstrates her academic leadership.
Research Interests:
Her research centers on the design and development of innovative nano- and macro-delivery platforms for pharmaceutical and cosmetic applications. She focuses on polymeric nanoparticles, hydrogels, bioactive compounds, and nanocrystals aimed at overcoming bioavailability challenges, particularly in cancer and neurodegenerative conditions. Dr. Gigliobianco is deeply invested in using waste-derived biomaterials for sustainable formulations. She applies advanced analytical techniques for material characterization and emphasizes nose-to-brain delivery strategies. Her work contributes to the evolution of eco-friendly, patient-centric therapies and fosters interdisciplinary collaborations in biomaterials, biotechnology, and therapeutic formulation.
Awards and Honors:
Dr.Maria Rosa Gigliobianco has received several prestigious accolades. she was awarded the MSCA Individual European Fellowship, a competitive grant for innovative European research. She earned “Best Poster Presentation” awards, including from the CRS Italy Chapter. Her master’s thesis was honored with the “Donna e Scienza” Rita Levi Montalcini award. She also received competitive fellowships from the University of Camerino during her Master’s and Ph.D. studies. These recognitions reflect her scientific excellence and commitment to advancing pharmaceutical technology through innovative research and public dissemination of knowledge.
Publications:
Title: Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability
Citations: 305
Published Year: 2018
Title: Hot Melt Extrusion: Highlighting Physicochemical Factors to Be Investigated While Designing and Optimizing a Hot Melt Extrusion Process
Citations: 152
Published Year: 2018
Title: Nano-medicine improving the bioavailability of small molecules for the prevention of neurodegenerative diseases
Citations: 32
Published Year: 2017
Title: New nanometric solid dispersions of glibenclamide in Neusilin® UFL2
Citations: 19
Published Year: 2016
Title: Formation, physicochemical characterization, and thermodynamic stability of the amorphous state of drugs and excipients
Citations: 12
Published Year: 2016
Title: Effect of poly (vinylpyrrolidone) or sodium alginate on the stability of the amorphous form of nimesulide
Citations: 8
Published Year: 2016
Title: Effect of Grinding on the Solid-State Stability and Particle Dissolution of Acyclovir Polymorphs
Citations: 7
Published Year: 2017
Conclusion:
Dr.Maria Rosa Gigliobianco is a highly qualified nominee for a research award recognizing excellence in nanomedicine and pharmaceutical sciences. Her multidisciplinary expertise, sustained research productivity, and commitment to training future scientists make her a valuable contributor to scientific advancement. Her projects address urgent healthcare challenges with innovative, sustainable, and practical solutions. Recognized by European institutions and academia, she continues to lead impactful research in cancer therapy, neurodegenerative diseases, and eco-friendly formulation technologies. Her achievements exemplify the caliber and vision required for global scientific recognition in medicine and biopharmaceutical innovation.